Study finds chemotherapy before surgery improves survival in early-stage pancreatic cancer

A Mayo Clinic study is providing new insights into how treatment sequence can affect survival in patients with early-stage pancreatic cancer, suggesting that many patients may benefit from receiving chemotherapy before surgery. The findings, published in the Journal of the National Comprehensive Cancer Network, were based on more than 1,400 patients treated across Mayo Clinic's campuses in Minnesota, Arizona, and Florida.